Antithymocyte-globulin/eculizumabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2043卷 / 1期

关键词：

D O I：

10.1007/s40278-025-75329-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：48 / 48

相关论文

共 50 条

[1] Antithymocyte-globulin/eculizumabLack of efficacy
Reactions Weekly, 2024, 2012 (1) : 50 - 50
[2] Antithymocyte-globulin/tacrolimusLack of efficacy: case report
Reactions Weekly, 2023, 1976 (1) : 46 - 46
[3] Antithymocyte-globulin/tocilizumabLack of efficacy: case report
Reactions Weekly, 2023, 1970 (1) : 43 - 43
[4] Antithymocyte-globulin/eltrombopagLack of efficacy: case report
Reactions Weekly, 2022, 1909 (1) : 85 - 85
[5] Antithymocyte-globulin/Busulfan/FludarabineLack of efficacy: case report
Reactions Weekly, 2024, 2038 (1) : 30 - 30
[6] Antithymocyte-globulin/Methotrexate/TacrolimusLack of efficacy: case report
Reactions Weekly, 2024, 2033 (1) : 43 - 43
[7] Antithymocyte-globulin/busulfan/cyclophosphamideLack of efficacy: case report
Reactions Weekly, 2022, 1914 (1) : 84 - 84
[8] Antithymocyte-globulin/cyclophosphamide/fludarabineLack of efficacy: case report
Reactions Weekly, 2023, 1967 (1) : 62 - 62
[9] Antithymocyte-globulin/cyclophosphamide/fludarabineLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 60 - 60
[10] Antithymocyte-globulin/Busulfan/FludarabineLack of efficacy: case report
Reactions Weekly, 2024, 2039 (1) : 71 - 71

← 1 2 3 4 5 →